p16ink4 immunoreactivity is a reliable marker for urothelial carcinoma in situ. (Q53324615)
Jump to navigation
Jump to search
scientific article published on 30 January 2008
| Language | Label | Description | Also known as |
|---|---|---|---|
| English | p16ink4 immunoreactivity is a reliable marker for urothelial carcinoma in situ. |
scientific article published on 30 January 2008 |
Statements
p16ink4 immunoreactivity is a reliable marker for urothelial carcinoma in situ (English)
Ming Yin
Sheldon Bastacky
Teresa McHale